Get started

ACB

ACB RESPECTING TRENDLINE ! Hello Traders, Today’s chart will be on ACB – AURORA CANNABIS INC, respected trend line perfectly! Points to consider, - Trend overall bullish - Broke resistance, now potential support on re-test - EMA’s turning bullish - Stochastic showing upwards momentum - RSI broke its resistance - Volume starting to increase - Next local resistance areas are the .382 and .618 Fibonacci Zones ACB has perfectly respected the upwards trend line and has broken local resistance now turning potential support upon retest. The EMA’s have turned bullish upon this break signifying that further upwards is more probable. The RSI is quite bullish at given time too, it has broken its major resistance line thus has further upside potential; this will allow bulls to push price into next local resistant zone (.328 Fib). Furthermore, the stochastic's are showing upwards momentum, however it’s starting to look over extended, we may see it cool of, this will allow for price to retest support before heading back up… Volume is starting to pick up, very healthy in this break from resistance, we need to see the volume maintain a steady increase for this area... Bulls can potentially test next resistant zone at the .382 Fib, posting a gain of around 18.64%, if a break of this zone comes to fruition, then a test of .618 Fibonacci is probable, posting a 50.81% gain! What are your thoughts on ACB? Will bull have the momentum to push through local resistances? Please leave a like and comment And remember, “It’s not whether you’re right or wrong that’s important, it’s how much money you make when you’re right and how much you lose when you’re wrong.” – George Soros
ALong
by AzizKhanZamani
ACB Moving into Earnings todaySlight bearish convergence on the Stoch, and also RSI indicating a possible hourly pullback. Earnings are guided, so the revenue figures are not very likely to drive the price upward. We're looking for profitability. ACB predicted Q4 profitability. The press release issueing earnings guidance only mentioned that they are moving closer to achieve positive EBITDA. Any disappointment on that front will see ACB retest key support at $5.89, and possibly the lower $5 range. ACB is currently at the top of its downtrend channel, after a nice bounce. Bulls are looking to break $6.30 on large volume to see the price move back up to test $6.65 and $6.83. Regardless of all the positive news and change in broader market sentiment, not a single pot stock has posted a higher high above a long term downtrend. I feel that all of the past few days' moves, has been correctional, and not neccessarily bullish. I do feel, however, personally, that the current price levels present excellent buying opportunities for long term investments. If your time span is 4 to 5 years, then ACB, APHA and CRON are buys. CGC, on the other hand, could still have significant downside. I think that the King of Cannabis is about to be de-throned. Has anybody considered Creso Labs, btw. No debt, pure USA play, excellent pressence, and much worth a closer look. Please share your thoughts?
A
by Barkworth
7
Aurora Cannabis. (ACB) Time to Start Buying?! Hey guys. So I have always been a fan of marijuana stocks and who can love trading the devils lettuce, but not trade ACB!? Over the summer we had a big sell off in the sector, but that was expected after the run we had that winter. The market is starting to catch some support and we are seeing more consistent green days for the green good. At this point in time you could do one of two things... you could wait it out, or what I personally do for longer term investments.. Start accumulating. We could bleed a little more, but to be honest... I dont see it falling much more. Another option for people who prefer less risk exposure could be to wait for earnings. Earnings is only a few weeks away and should provide a significant outlook for Auroras future.
A
by Augustus_Lee7
3
ACB what is it going to be?The smartest company in the game, still in charge of their own board. Guided earnings, moving closer to positive EBITDA, I think we can safely say that Aurora is not burning through a Billion $ per quarter. We won't see $250.000.000 losses per quarter either. ACB doesn't 'deserve' to be dragged down by broader market fears. By now, it is clear that ACB SHOULD really be the biggest cannabis company by market cap. I believe this will happen before long, but until that time comes, we still need to look at the daily charts for short term direction. Personally, I think ACB is stuck between key support $5.50 and key resistance $6.20. Buyers will get on board above $6.20, but if bulls can't hold $5.50, we'll see a continued move down, to $5.35 and perhaps even $4.80. Not the strongest stock to hold in case a recession sets in, but that could still be months away, and may in fact never happen. Just my 2 cents, its free...
A
by Barkworth
10
ACB Trendline Bounce TradeACB appears to be in a good buy spot here- This stock along with many of the marijuana names have been beaten up in the last few weeks/months. The price is on/near the diagonal bullish trendline it has respected for a long period. Although it is not the strongest of trendlines with only 3 real bounces. I do think the risk meets tbe reward here. Im looking at a trade just under 5:1. Close any weekly candle close below the trendline. Take profit at the moving average. If it breaks the moving average in a strong way I will update my price targets. Happy Trading :)
TSX:ACBLong
by andzd
DMF vs Aurora Cannabis (NYSE:ACB) - A Two Week Performance StudyHey Traders! Today we're looking at how the Directional Momentum Flux (DMF) strategy performed against Aurora Cannabis Inc (NYSE: ACB) during a two-week study period. Overall performance of ACB was not very strong during the period (7/15 to 7/31/2019), but DMF was able to identify many momentum inflection points and capture quite a decent return of around 44%. Check out the video and join the discussion below! Happy trading! Links: Directional Momentum Flux Strategy
A
by ccashwell
3
$OGI Showing Signs of a Bottom Despite Continued Sector Rout$OGI has held the 200DMA as support the last two trading sessions & on July 15th. Hammer candle was put in on 7/29 followed by a bullish engulfing signal today. OGI current trades at a 10x P/E 2019 revenue and a 3-4x P/E on FY2020 revenue estimates. We see several near-term catalysts for $OGI and feel the stock will benefit immensely once the current industry chaos settles down (CTST, APHA, HEXO, etc) The company announced July 15th, it developed a Rapid-Onset Nano-Emulsification Technology for Cannabis Beverages with an initial onset of 10-15 mins vs 60-90 mins on average. The company also clearly told the market they're actively seeking a beverage partner & is for sale. Management has proven they can execute with positive adjusted EBITDA 4x Qs in a row, minimal dilution to shareholders vs peers, disciplined w/ expenses (No $600M losses here), and a very transparent with investors. $OGI management won't pump the stock & give unrealistic guidance like some of its peers, $OGI is focused on building an operationally sound profitable cannabis company in Canada & Internationally. We expect $OGI to get a lot of attention from institutional & retail investors state-side in 2H 2019 as investors begin to pay more attention to market caps, margins, profit/loss, etc. The industry is maturing very quickly and we believe investors will begin to see $OGI as a Top 3 LP. Time will tell... ***Disclaimer: I am long $OGI. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.***
NASDAQ:OGILong
by cb035
1
ACB never broke downtrend yetDespite all these posts about how it is going to break out now, then now, and then now, it has never once really broken its downtrend, after peaking at 10.38, so very extendedly so. Realistically, we're about the see the third Death Cross, and the price recently bounced on the 300EMA, then on its long time psychological support/resistance of $7.00. There is a lot of room down before this may become a bullish play again. 3.5 billion $ good will on its balance sheet. Lots of debt, operating at a loss. This is not a company that'll do well in an economic downturn. Another thing to keep in mind, is that it had a float of roughly 800 million shares when it peaked at 12.50, so long ago. It recently peaked at 2.2 Dollars lower. Could this be because of the increased float? She's slower to move up now, have you noticed? Anyways, if the opposite is true, we'll be looking at $4 or lower, once the industry bottoms out. I have been wondering, should I play on the "deals to be announced within 6 months". I'm thinking investors are looking for equity deals. Selling CBD oil to which ever company is certainly not going to change much, fundamentally. To be honest, ACB was my favourite play. But then dilution, goodwill and debt set in. ACB is still my bet to become a top player in the industry, but as a company that'll be struggling to survive for at least another year or two, I doubt that it'll produce a very interesting stock price. Besides, the float is so extreme, that when volume increases to about 100 million, the price will only move about 8 to 10%. You see this every time. It opens 4% up, pre market, then drops at opening. Last rally I just bought that opening dip, and closed my position at EOD. Didn't lose a penny on its downtrend. PS. Did you know that NRTH is consistently posting results with positive EBITDA? This is a very interesting company, and it is about to accumulate again. No debt, and profitable. When SPY dropped hard last week, NRTH didn't budge a penny. Is that a coincidence, or is this a fundamentally strong company? My 2 cents.
A
by Barkworth
3